Apyx Medical Statistics
Total Valuation
Apyx Medical has a market cap or net worth of $42.27 million. The enterprise value is $48.12 million.
Important Dates
The next confirmed earnings date is Friday, November 8, 2024, before market open.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Apyx Medical has 34.64 million shares outstanding. The number of shares has increased by 0.15% in one year.
| Current Share Class | 34.64M |
| Shares Outstanding | 34.64M |
| Shares Change (YoY) | +0.15% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 16.18% |
| Owned by Institutions (%) | 28.19% |
| Float | 25.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.85 |
| Forward PS | 0.80 |
| PB Ratio | 2.84 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.33, with a Debt / Equity ratio of 2.59.
| Current Ratio | 5.33 |
| Quick Ratio | 4.27 |
| Debt / Equity | 2.59 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.93 |
Financial Efficiency
Return on equity (ROE) is -110.25% and return on invested capital (ROIC) is -26.64%.
| Return on Equity (ROE) | -110.25% |
| Return on Assets (ROA) | -21.83% |
| Return on Capital (ROIC) | -26.64% |
| Revenue Per Employee | $194,567 |
| Profits Per Employee | -$112,571 |
| Employee Count | 252 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 1.82 |
Taxes
| Income Tax | -128,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.55% in the last 52 weeks. The beta is 1.21, so Apyx Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | -52.55% |
| 50-Day Moving Average | 1.21 |
| 200-Day Moving Average | 1.50 |
| Relative Strength Index (RSI) | 51.76 |
| Average Volume (20 Days) | 32,825 |
Short Selling Information
The latest short interest is 234,863, so 0.68% of the outstanding shares have been sold short.
| Short Interest | 234,863 |
| Short Previous Month | 236,052 |
| Short % of Shares Out | 0.68% |
| Short % of Float | 0.91% |
| Short Ratio (days to cover) | 5.49 |
Income Statement
In the last 12 months, Apyx Medical had revenue of $49.03 million and -$28.37 million in losses. Loss per share was -$0.82.
| Revenue | 49.03M |
| Gross Profit | 30.35M |
| Operating Income | -22.33M |
| Pretax Income | -28.50M |
| Net Income | -28.37M |
| EBITDA | -21.67M |
| EBIT | -22.33M |
| Loss Per Share | -$0.82 |
Full Income StatementBalance Sheet
The company has $32.68 million in cash and $38.70 million in debt, giving a net cash position of -$6.02 million or -$0.17 per share.
| Cash & Cash Equivalents | 32.68M |
| Total Debt | 38.70M |
| Net Cash | -6.02M |
| Net Cash Per Share | -$0.17 |
| Equity (Book Value) | 14.92M |
| Book Value Per Share | 0.43 |
| Working Capital | 46.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.19 million and capital expenditures -$591,000, giving a free cash flow of -$9.78 million.
| Operating Cash Flow | -9.19M |
| Capital Expenditures | -591,000 |
| Free Cash Flow | -9.78M |
| FCF Per Share | -$0.28 |
Full Cash Flow StatementMargins
Gross margin is 61.90%, with operating and profit margins of -45.53% and -57.86%.
| Gross Margin | 61.90% |
| Operating Margin | -45.53% |
| Pretax Margin | -58.34% |
| Profit Margin | -57.86% |
| EBITDA Margin | -44.20% |
| EBIT Margin | -45.53% |
| FCF Margin | -19.94% |
Dividends & Yields
Apyx Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.15% |
| Shareholder Yield | -0.15% |
| Earnings Yield | -67.67% |
| FCF Yield | -23.32% |
Analyst Forecast
The average price target for Apyx Medical is $5.00, which is 309.84% higher than the current price. The consensus rating is "Hold".
| Price Target | $5.00 |
| Price Target Difference | 309.84% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 12.28% |
| EPS Growth Forecast (5Y) | -43.69% |
Stock ForecastsStock Splits
The last stock split was on January 6, 1994. It was a reverse split with a ratio of 0.06666:1.
| Last Split Date | Jan 6, 1994 |
| Split Type | Reverse |
| Split Ratio | 0.06666:1 |
Scores
Apyx Medical has an Altman Z-Score of 0.1 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.1 |
| Piotroski F-Score | 2 |